PMID- 17245394 OWN - NLM STAT- MEDLINE DCOM- 20070605 LR - 20071115 IS - 0085-2538 (Print) IS - 0085-2538 (Linking) VI - 71 IP - 6 DP - 2007 Mar TI - Interaction between proximal tubular epithelial cells and infiltrating monocytes/T cells in the proteinuric state. PG - 526-38 AB - We hypothesize an interaction between T cells/monocytes and the tubules in the development of tubulointerstitial injury in chronic proteinuric nephropathy. We established in vitro co-culture systems of proximal tubular epithelial cells (PTEC) and T cells/monocytes to study the contribution of soluble factors and cell-to-cell contact in the development of tubulointerstitial injury. The release of monocyte chemoattractant protein-1 (MCP1 or CCL2), Regulated upon Activation, normal T cell Expressed and Secreted (RANTES or CCL5), soluble intracellular adhesion molecules-1 (sICAM-1), or interleukin-6 (IL-6) was increased in PTEC following apical exposure to human serum albumin (HSA). The release of CCL2, CCL5, or sICAM-1 from PTEC was enhanced by contact of monocytes/T cells on the basolateral surface. Tumor necrosis factor-alpha (TNF-alpha) and IL-1beta are important soluble factors as suggested by the blocking effect of antibodies (Abs) against TNF-alpha or IL-1beta but not against other cytokines. The percentage of CD4+ T cells expressing both chemokine receptors, CCR2 and CCR5, was increased after culturing with supernatant from the apical or basolateral surface of PTEC following apical exposure to HSA. However, only CCR2 was upregulated in CD8+ T cells, whereas CCR5 expression was increased in monocytes. The chemotaxis of CD4+ or CD8+ T cells to supernatant from PTEC upon apical exposure to HSA was reduced with neutralizing Abs against CCL5 and/or CCL2, whereas the chemotaxis of monocytes was only reduced by anti-CCL5 but not by anti-CCL2. In summary, chemokines released by HSA-activated PTEC are amplified by monocytes/T cells. Mediators released by HSA-activated PTEC can differentially modulate the expression of chemokine receptors in monocytes/T cells and hence, alter their chemotaxis towards activated PTEC. These interactions are pivotal in the development of tubulointerstitial injury. FAU - Lai, K N AU - Lai KN AD - Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China. knlai@hku.hk FAU - Leung, J C K AU - Leung JC FAU - Chan, L Y Y AU - Chan LY FAU - Guo, H AU - Guo H FAU - Tang, S C W AU - Tang SC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070124 PL - United States TA - Kidney Int JT - Kidney international JID - 0323470 RN - 0 (CCL2 protein, human) RN - 0 (CCL5 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CCL5) RN - 0 (Chemokines, CC) RN - 0 (Interleukin-2 Receptor alpha Subunit) RN - 0 (Interleukin-6) RN - 0 (Receptors, Chemokine) RN - 0 (Serum Albumin) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) SB - IM MH - Cell Communication/*physiology MH - Cells, Cultured MH - Chemokine CCL2/genetics/metabolism MH - Chemokine CCL5 MH - Chemokines, CC/genetics/metabolism MH - Chemotaxis/drug effects/physiology MH - Coculture Techniques MH - Epithelial Cells/drug effects/metabolism/*pathology MH - Gene Expression Regulation/drug effects/physiology MH - Humans MH - Intercellular Adhesion Molecule-1/genetics/metabolism MH - Interleukin-2 Receptor alpha Subunit/genetics/metabolism MH - Interleukin-6/genetics/metabolism MH - Kidney Tubules, Proximal/drug effects/metabolism/*pathology MH - Monocytes/*pathology/physiology MH - Proteinuria/*pathology/physiopathology MH - Receptors, Chemokine/genetics/metabolism MH - Serum Albumin/pharmacology MH - T-Lymphocytes/*pathology/physiology EDAT- 2007/01/25 09:00 MHDA- 2007/06/06 09:00 CRDT- 2007/01/25 09:00 PHST- 2007/01/25 09:00 [pubmed] PHST- 2007/06/06 09:00 [medline] PHST- 2007/01/25 09:00 [entrez] AID - S0085-2538(15)52413-7 [pii] AID - 10.1038/sj.ki.5002091 [doi] PST - ppublish SO - Kidney Int. 2007 Mar;71(6):526-38. doi: 10.1038/sj.ki.5002091. Epub 2007 Jan 24.